Short-term Safety and Mid-term Efficacy of Prasugrel Versus Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention

OBJECTIVE: Although several clinical trials have shown that the mid- and long-term safety and efficacy of prasugrel are better than those of clopidogrel after percutaneous coronary intervention (PCI), there are few data regarding the short-term safety. METHODS: In this study, we retrospectively anal...

Descripción completa

Detalles Bibliográficos
Autores principales: Koyabu, Yota, Abe, Shichiro, Sakuma, Masashi, Kanaya, Tomoaki, Obi, Syotaro, Yoneda, Shuichi, Toyoda, Shigeru, Nakajima, Toshiaki, Inoue, Teruo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746638/
https://www.ncbi.nlm.nih.gov/pubmed/31118376
http://dx.doi.org/10.2169/internalmedicine.2262-18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746638/
https://www.ncbi.nlm.nih.gov/pubmed/31118376
http://dx.doi.org/10.2169/internalmedicine.2262-18

Ejemplares similares